Clinical Trial

Virtual Reality Digital Therapeutics for Seasonal Affective Disorder

Study acronym: VR-SAD
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Seasonal Affective Disorder (SAD) is commonly treated with bright light therapy. Virtual reality (VR) is an immersive computer-generated environment, which has been used to treat mental health difficulties, such as depression, social anxiety and stress. This study aims to compare the use of VR with bright light therapy in treating SAD. Participants will be randomly allocated to either the VR condition or the light box condition and instructed to use the respective device every day for 14 days.
Trial Details
NCT Number NCT07161570
Lead Sponsor Anglia Ruskin University
Collaborators: Reneural Technologies Ltd., Aerial Icon Ltd., Innovate UK, UKRI
Conditions Seasonal Affective Disorder (SAD)
Enrollment 60 participants
Start Date 2025-10-27
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-08